Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2016
/
Article
/
Tab 4
/
Research Article
Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
Table 4
Publication bias.
Egger’s publication test
value
Response rate
0.035
Disease control rate
0.455
KPS
0.046
Decline of leucocyte count
0.448
Anemia
0.182
Decline of platelet count
0.029
Nausea and vomiting
0.159
Hepatic dysfunction
0.023
Alopecia
0.285
Overall survival
0.083